Emergence of KRAS mutations and acquired resistance to anti-EGFR therapy in colorectal cancer
University of Turin · Candiolo Cancer Institute · +3 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
1,889
total citations
- FWCI
- 71.59
- Percentile
- 100%
- References
- 25
Citations per year
Authors
26Topics & keywords
Topics
Keywords
- Cetuximab
- KRAS
- Panitumumab
- Colorectal cancer
- Cancer research
- Epidermal growth factor receptor
- Medicine
- EGFR inhibitors
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.